Search Results 61-70 of 16288 for monoclonal antibody
Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13 · More about research at Mayo Clinic.
Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as atezolizumab, may interfere ...
Mayo Clinic was a worldwide leader in using monoclonal antibody therapy. This therapy significantly reduced the hospitalization rate and decreased mortality of ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer ...
A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...
The Antibody Hybridoma Core at Mayo Clinic produces monoclonal antibodies using immunized mice housed in a pathogen-free colony.
Purified monoclonal antibodies can be labeled with fluorescein isothiocyanate, biotin and rhodamine fluorochromes. Antibody samples to be labeled should each be ...
Mayo Clinic researchers study and develop a COVID-19 diagnostic test, an antibody test, monoclonal antibody medications, convalescent plasma therapy and ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...
Duvelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.